Generali Investments Towarzystwo Funduszy Inwestycyjnych Exact Sciences Corp Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $192 Billion
- Q2 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Exact Sciences Corp stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 28,000 shares of EXAS stock, worth $1.5 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
28,000
Previous 30,000
6.67%
Holding current value
$1.5 Million
Previous $1.3 Billion
14.57%
% of portfolio
0.78%
Previous 0.82%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$972 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$957 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$645 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$641 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$287 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.45B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...